Quarterly report pursuant to Section 13 or 15(d)

Equity and Stock-Based Compensation

v3.20.2
Equity and Stock-Based Compensation
9 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Equity and Stock-Based Compensation

7.  Equity and Stock-Based Compensation

Stock-based compensation expense was $0.1 million in each of the three months ended June 30, 2020 and 2019, and was $0.3 million and $0.5 million in the nine months ended June 30, 2020 and 2019, respectively.  Stock-based compensation expense is included in selling, general and administrative expenses.

The following table summarizes our stock option activity during the nine months ended June 30, 2020:

 

 

 

Options

 

 

Weighted

Average

Exercise Price

 

Outstanding at beginning of period

 

 

1,068,665

 

 

$

7.04

 

Granted

 

 

32,500

 

 

 

5.34

 

Exercised

 

 

(145,375

)

 

 

5.50

 

Forfeited

 

 

(215,894

)

 

 

7.65

 

Outstanding at end of period

 

 

739,896

 

 

$

7.08

 

Exercisable at end of period

 

 

630,773

 

 

$

7.36

 

Weighted average fair value of options granted

   during the period

 

$

2.89

 

 

 

 

 

 

The fair value of options was estimated at the applicable grant date using the Black-Scholes option pricing model with the following assumptions:

 

 

 

Nine Months Ended June 30, 2020

 

Risk free interest rate

 

 

1

%

Expected life

 

6 years

 

Dividend rate

 

 

%

Volatility

 

 

58

%

 

On November 29, 2018, we announced that our Board approved a stock repurchase program, pursuant to which we may repurchase up to $4 million of our outstanding common stock, par value $0.01 per share (“Common Stock”), over a one-year period. Repurchases under the program were to be made in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in compliance with the rules and regulations of the SEC; however, we had no obligation to repurchase shares and the timing, actual number, and value of shares to be repurchased was subject to management’s discretion and depended on the Company’s stock price and other market conditions. Our Board could have terminated the repurchase program at any time while it was in effect.  We intended to retire any repurchased shares.  The term of our repurchase program expired as of the quarter ended December 31, 2019.  There were no shares repurchased under this plan.

 

On February 4, 2020, the Board approved a new stock repurchase program, pursuant to which the Company may repurchase up to $4 million of its outstanding Common Stock over a one-year period, commencing on February 10, 2020. Repurchases under the program will be made in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in compliance with the rules and regulations of the SEC; however, the Company has no obligation to repurchase shares and the timing, actual number, and value of shares to be repurchased is subject to management’s discretion and will depend on the Company’s stock price and other market conditions. The Company may, in the sole discretion of the Board, terminate the repurchase program at any time while it is in effect. During the quarter ended March 31, 2020, we repurchased 366,000 shares of our Common Stock on the open market at a total cost of approximately $2.0 million (an average price of $5.46 per share).